Literature DB >> 8629997

Role of protein phosphatase 2A in the regulation of mitogen-activated protein kinase activity in ventricular cardiomyocytes.

S Braconi Quintaje1, D J Church, M Rebsamen, M B Valloton, B A Hemmings, U Lang.   

Abstract

Incubation of cultured, neonatal rat ventricular cardiomyocytes with 100 nM phorbol 12-myristate-13-acetate (PMA) induced a transient suppression of PP2A activity at 5 min, an effect that was reversed after 15 min of exposure to PMA. This inactivation was correlated with a transient increase in the phosphorylation level of the catalytic subunit of PP2A (193 +/- 38% of control levels at 5 min). Simultaneously to the transient inactivation of PP2A, we observed a rapid and reversible phosphorylation of 42-kDa MAP kinase (474 +/- 65% of control levels at 5 min, and 316 +/- 44% at 15 min) in cardiomyocytes treated with PMA. This transient phosphorylation was accompanied by a transient increase in cytosolic MAP kinase activity (209 +/- 17% of control values at 5 min and 125 +/- 7% at 15 min). Okadaic acid (1 microM ) completely blocked the decrease in the phosphorylation level and activity of MAP kinase occurring after 5 min of exposure to PMA. These data demonstrate that PP2A inactivation and MAP kinase activation are very strongly correlated in cardiomyocytes, indicating that PP2A plays a negative modulatory role in the regulation of MAP kinase activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8629997     DOI: 10.1006/bbrc.1996.0632

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Induction of p53-independent apoptosis by the adenovirus E4orf4 protein requires binding to the Balpha subunit of protein phosphatase 2A.

Authors:  R C Marcellus; H Chan; D Paquette; S Thirlwell; D Boivin; P E Branton
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

2.  A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling.

Authors:  Mariko Hatakeyama; Shuhei Kimura; Takashi Naka; Takuji Kawasaki; Noriko Yumoto; Mio Ichikawa; Jae-Hoon Kim; Kazuki Saito; Mihoro Saeki; Mikako Shirouzu; Shigeyuki Yokoyama; Akihiko Konagaya
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

3.  PME-1 protects extracellular signal-regulated kinase pathway activity from protein phosphatase 2A-mediated inactivation in human malignant glioma.

Authors:  Pietri Puustinen; Melissa R Junttila; Sari Vanhatupa; Anna A Sablina; Melissa E Hector; Kaisa Teittinen; Olayinka Raheem; Kirsi Ketola; Shujun Lin; Juergen Kast; Hannu Haapasalo; William C Hahn; Jukka Westermarck
Journal:  Cancer Res       Date:  2009-03-17       Impact factor: 12.701

4.  Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6, similar to that in Alzheimer's disease.

Authors:  Jin-Jing Pei; Cheng-Xin Gong; Wen-Lin An; Bengt Winblad; Richard F Cowburn; Inge Grundke-Iqbal; Khalid Iqbal
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

5.  PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif.

Authors:  R Pulido; A Zúñiga; A Ullrich
Journal:  EMBO J       Date:  1998-12-15       Impact factor: 11.598

Review 6.  Anp32e (Cpd1) and related protein phosphatase 2 inhibitors.

Authors:  Tomás A Santa-Coloma
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

7.  Label-free quantitative phosphoproteomics with novel pairwise abundance normalization reveals synergistic RAS and CIP2A signaling.

Authors:  Otto Kauko; Teemu Daniel Laajala; Mikael Jumppanen; Petteri Hintsanen; Veronika Suni; Pekka Haapaniemi; Garry Corthals; Tero Aittokallio; Jukka Westermarck; Susumu Y Imanishi
Journal:  Sci Rep       Date:  2015-08-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.